Panoramic banner for design. As a pharmacist working in the ... to expand the use of these effective, cost-saving biosimilar drugs. One challenge to biosimilar adoption and true value creation ...

But unlike the development of innovator biologics—or generic versions of chemical-based medications ... unlikely or challenging, biosimilar developers must design the development program ...

Witnesses at the April 8 hearing told legislators biosimilars save patients and taxpayers money, that pharmacy benefit ...

Biosimilars are near-identical versions of biologic cancer drugs, available at lower costs. Germany saves hundreds of millions annually from just one biosimilar drug. Patient mistrust and policy ...

Biosimilar drugs are alternatives to the U.S. Food and ... therapy classes where they are available. With this formulary design, we have been able to achieve more than 94% use of biosimilars ...

In this episode of the Drug Solutions Podcast ... as a bioprocess engineer at Biocon Biologics for six years, contributing to the design of purification platforms for biosimilars and innovator ...

In an interview, James D. Chambers, Ph.D., from Tufts Medical Center, talks about the factors that are impacting the ...

The first adalimumab biosimilar ... of Michigan Center for Value-based Insurance Design. Generally, a consumer's co-pay is a percentage of a drug's list price, so it stands to reason that a ...

These disparities may be due to design ... on biosimilar coverage.” According to the news reporters, the research concluded: “Given ample evidence of a relationship between drug coverage ...

Switching from one biosimilar medication to another is safe and effective ... "The studies were heterogeneous in size, design, and endpoints, providing data on safety, effectiveness ...

Biosimilars hold the promise of substantial potential cost savings in health care with no compromise in the efficacy and safety of treatment. Despite this, their adoption in the United States has ...

Traditionally, PBMs will still cover the brand name drug even if the low-cost biosimilars are available ... pharmacy based on the member’s benefit design, price, turnaround time, fulfillment ...